Teladoc Health, Inc.·4

Dec 5, 4:06 PM ET

GOREVIC JASON N 4

4 · Teladoc Health, Inc. · Filed Dec 5, 2023

Insider Transaction Report

Form 4
Period: 2023-12-01
Gorevic Jason N
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-015,61528,075 total
    Common Stock (5,615 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-01+5,615604,611 total
  • Sale

    Common Stock

    2023-12-04$18.90/sh2,877$54,381601,734 total
Footnotes (3)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  • [F3]On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Documents

1 file
  • 4
    wk-form4_1701810368.xmlPrimary

    FORM 4